Novelix Pharmaceuticals share news and announcements
BSE: 536565Healthcare ServicesSmall Cap
Last close ₹59.54down ₹3.19 (5.09%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹62.73.
52-week range of traded prices to 23 Oct 2026
₹45.03Low, 23 Oct 2025₹92.00High, 16 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹170 Cr2,861st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 46.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 11.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 8.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.09
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,524
Novelix Pharmaceuticals share news and announcements
605 announcements, routine notices left out, newest first. Page 5 of 13.
Mar 2024
Feb 2024
29 Feb · Board meeting
Meeting on 5 Mar 2024: preferential issue of shares
Jan 2024
30 Jan · Results
23 Jan · Board meeting
Meeting on 30 Jan 2024: quarterly results
Dec 2023
15 Dec · Board meeting
8 Dec · Board meeting
Meeting on 15 Dec 2023: quarterly results
Nov 2023
Oct 2023
17 Oct · Results
12 Oct · Board meeting
Meeting on 17 Oct 2023: quarterly results
Sep 2023
Aug 2023
23 Aug · Meeting
10 Aug · Board meeting
9 Aug · Results
3 Aug · Board meeting
Meeting on 9 Aug 2023: quarterly results
Apr 2023
20 Apr · Board meeting
Meeting on 29 Apr 2023: audited results18 Apr · Compliance Certificate U/R. 40(9)
Mar 2023
Feb 2023
1 Feb · Board meeting
Meeting on 9 Feb 2023: quarterly results
Jan 2023
9 Jan · Meeting
Dec 2022
5 Dec · Board meeting
Meeting on 5 Dec 20225 Dec · Board meeting
Nov 2022
11 Nov · Results
1 Nov · Board meeting
Meeting on 11 Nov 2022: quarterly results
Oct 2022
18 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Aug 2022
20 Aug · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/536565 ....19 Aug · Meeting
2 Aug · Board meeting
Meeting on 10 Aug 2022: quarterly results
Jul 2022
28 Jul · Meeting
28 Jul · Reg. 34 (1) Annual Report.
27 Jul · Board meeting
19 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
7 Jun · Management